Hemo.Labs (Umaia)

Under review · founded 2024
HealthTech & MedTech Open sources

Intelligent analysis of laboratory blood tests and personalized preventive health recommendations.

About

Hemo.Labs (developer of the consumer app Umaia) is a Kazakhstani preventive health HealthTech startup founded by Alua Musralina (Founder & CEO). According to its corporate LinkedIn profile, the company was founded in 2024; a permanent headquarters in Astana requires separate confirmation. The service analyzes a user’s laboratory blood test results and biomarkers to generate personalized recommendations for physical activity, sleep, and nutrition. The project was a finalist at Astana Hub Battle 2025, completed the Draper University Hero Program accelerator (Silicon Valley) with support from the Go Abroad program, and was showcased at TechCrunch Disrupt 2025. Participation in accelerator and support programs does not constitute an investment transaction, and venture funding remains under verification. A seed round fundraising request has been removed from active statuses pending dated confirmation from the company.

Founders

AM
Alua MusralinaFounder & CEO

Team information is compiled from open sources and may be updated by our editors.

RAEM Coverage

Profile history

Profile published in directory
Editorial data verification

Sources

Is this your company?

Verify that you represent Hemo.Labs (Umaia) to update this profile and receive inquiries from investors and partners.

Similar startups

All in sector →
Hemo.Labs (Umaia)HealthTech · Under reviewWebsite ↗
REPRESENTATIVE VERIFICATION

Claim company representative access

Verified representatives can update metrics, publish company news to the feed, and receive direct investor inquiries.

✓

Request sent